ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pertussis Booster Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-38Q16707
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pertussis Booster Vaccine Market Research Report 2024
BUY CHAPTERS

Global Pertussis Booster Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-38Q16707
Report
November 2025
Pages:146
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

Pertussis Booster Vaccine Market

The global Pertussis Booster Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pertussis booster vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
From a downstream perspective, 12 Months Below accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pertussis Booster Vaccine leading manufacturers including Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Sanofi Pasteur leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pertussis Booster Vaccine market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pertussis Booster Vaccine Market Report

Report Metric Details
Report Name Pertussis Booster Vaccine Market
Segment by Type
  • Acellular Vaccines
  • Whole-Cell Vaccines
Segment by Application
  • 12 Months Below
  • 12 Months Above
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pertussis Booster Vaccine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pertussis Booster Vaccine Market report?

Ans: The main players in the Pertussis Booster Vaccine Market are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology

What are the Application segmentation covered in the Pertussis Booster Vaccine Market report?

Ans: The Applications covered in the Pertussis Booster Vaccine Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the Pertussis Booster Vaccine Market report?

Ans: The Types covered in the Pertussis Booster Vaccine Market report are Acellular Vaccines, Whole-Cell Vaccines

1 Study Coverage
1.1 Introduction to Pertussis Booster Vaccine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pertussis Booster Vaccine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Acellular Vaccines
1.2.3 Whole-Cell Vaccines
1.3 Market Segmentation by Application
1.3.1 Global Pertussis Booster Vaccine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pertussis Booster Vaccine Revenue Estimates and Forecasts 2020-2031
2.2 Global Pertussis Booster Vaccine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pertussis Booster Vaccine Sales Estimates and Forecasts 2020-2031
2.4 Global Pertussis Booster Vaccine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pertussis Booster Vaccine Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pertussis Booster Vaccine Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Acellular Vaccines Market Size by Manufacturers
3.5.2 Whole-Cell Vaccines Market Size by Manufacturers
3.6 Global Pertussis Booster Vaccine Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pertussis Booster Vaccine Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pertussis Booster Vaccine Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pertussis Booster Vaccine Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pertussis Booster Vaccine Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pertussis Booster Vaccine Sales and Revenue by Type (2020-2031)
6.4 North America Pertussis Booster Vaccine Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pertussis Booster Vaccine Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pertussis Booster Vaccine Sales and Revenue by Type (2020-2031)
7.4 Europe Pertussis Booster Vaccine Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pertussis Booster Vaccine Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pertussis Booster Vaccine Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pertussis Booster Vaccine Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pertussis Booster Vaccine Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pertussis Booster Vaccine Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pertussis Booster Vaccine Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pertussis Booster Vaccine Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pertussis Booster Vaccine Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pertussis Booster Vaccine Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pertussis Booster Vaccine Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.1.4 Sanofi Pasteur Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Sanofi Pasteur Pertussis Booster Vaccine Sales by Product in 2024
11.1.6 Sanofi Pasteur Pertussis Booster Vaccine Sales by Application in 2024
11.1.7 Sanofi Pasteur Pertussis Booster Vaccine Sales by Geographic Area in 2024
11.1.8 Sanofi Pasteur Pertussis Booster Vaccine SWOT Analysis
11.1.9 Sanofi Pasteur Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Business Overview
11.2.3 GSK Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.2.4 GSK Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 GSK Pertussis Booster Vaccine Sales by Product in 2024
11.2.6 GSK Pertussis Booster Vaccine Sales by Application in 2024
11.2.7 GSK Pertussis Booster Vaccine Sales by Geographic Area in 2024
11.2.8 GSK Pertussis Booster Vaccine SWOT Analysis
11.2.9 GSK Recent Developments
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Corporation Information
11.3.2 Mitsubishi Tanabe Pharma Business Overview
11.3.3 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.3.4 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales by Product in 2024
11.3.6 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales by Application in 2024
11.3.7 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales by Geographic Area in 2024
11.3.8 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine SWOT Analysis
11.3.9 Mitsubishi Tanabe Pharma Recent Developments
11.4 KM Biologics
11.4.1 KM Biologics Corporation Information
11.4.2 KM Biologics Business Overview
11.4.3 KM Biologics Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.4.4 KM Biologics Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 KM Biologics Pertussis Booster Vaccine Sales by Product in 2024
11.4.6 KM Biologics Pertussis Booster Vaccine Sales by Application in 2024
11.4.7 KM Biologics Pertussis Booster Vaccine Sales by Geographic Area in 2024
11.4.8 KM Biologics Pertussis Booster Vaccine SWOT Analysis
11.4.9 KM Biologics Recent Developments
11.5 Wuhan Institute of Biological Products
11.5.1 Wuhan Institute of Biological Products Corporation Information
11.5.2 Wuhan Institute of Biological Products Business Overview
11.5.3 Wuhan Institute of Biological Products Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.5.4 Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales by Product in 2024
11.5.6 Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales by Application in 2024
11.5.7 Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales by Geographic Area in 2024
11.5.8 Wuhan Institute of Biological Products Pertussis Booster Vaccine SWOT Analysis
11.5.9 Wuhan Institute of Biological Products Recent Developments
11.6 Walvax Biotechnology
11.6.1 Walvax Biotechnology Corporation Information
11.6.2 Walvax Biotechnology Business Overview
11.6.3 Walvax Biotechnology Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.6.4 Walvax Biotechnology Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Walvax Biotechnology Recent Developments
11.7 Chengdu Institute of Biological Products
11.7.1 Chengdu Institute of Biological Products Corporation Information
11.7.2 Chengdu Institute of Biological Products Business Overview
11.7.3 Chengdu Institute of Biological Products Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.7.4 Chengdu Institute of Biological Products Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Chengdu Institute of Biological Products Recent Developments
11.8 Minhai Biotechnology
11.8.1 Minhai Biotechnology Corporation Information
11.8.2 Minhai Biotechnology Business Overview
11.8.3 Minhai Biotechnology Pertussis Booster Vaccine Product Models, Descriptions and Specifications
11.8.4 Minhai Biotechnology Pertussis Booster Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Minhai Biotechnology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pertussis Booster Vaccine Industry Chain
12.2 Pertussis Booster Vaccine Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pertussis Booster Vaccine Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pertussis Booster Vaccine Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pertussis Booster Vaccine Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pertussis Booster Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
List of Tables
 Table 1. Global Pertussis Booster Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pertussis Booster Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pertussis Booster Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pertussis Booster Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pertussis Booster Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pertussis Booster Vaccine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global Pertussis Booster Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 8. Global Pertussis Booster Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pertussis Booster Vaccine Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global Pertussis Booster Vaccine Sales Share by Manufacturers (2020-2025)
 Table 12. Global Pertussis Booster Vaccine Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Pertussis Booster Vaccine Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Pertussis Booster Vaccine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Booster Vaccine as of 2024)
 Table 16. Global Pertussis Booster Vaccine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Pertussis Booster Vaccine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Pertussis Booster Vaccine Manufacturing Base and Headquarters
 Table 19. Global Pertussis Booster Vaccine Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Pertussis Booster Vaccine Sales by Type (2020-2025) & (K Dose)
 Table 23. Global Pertussis Booster Vaccine Sales by Type (2026-2031) & (K Dose)
 Table 24. Global Pertussis Booster Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Pertussis Booster Vaccine Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Pertussis Booster Vaccine ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Pertussis Booster Vaccine Sales by Application (2020-2025) & (K Dose)
 Table 29. Global Pertussis Booster Vaccine Sales by Application (2026-2031) & (K Dose)
 Table 30. Pertussis Booster Vaccine High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Pertussis Booster Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Pertussis Booster Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Pertussis Booster Vaccine ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Pertussis Booster Vaccine Growth Accelerators and Market Barriers
 Table 37. North America Pertussis Booster Vaccine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Pertussis Booster Vaccine Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Pertussis Booster Vaccine Growth Accelerators and Market Barriers
 Table 40. Europe Pertussis Booster Vaccine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Pertussis Booster Vaccine Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Pertussis Booster Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Pertussis Booster Vaccine Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Pertussis Booster Vaccine Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Pertussis Booster Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Pertussis Booster Vaccine Investment Opportunities and Key Challenges
 Table 47. Central and South America Pertussis Booster Vaccine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Pertussis Booster Vaccine Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Pertussis Booster Vaccine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Sanofi Pasteur Corporation Information
 Table 51. Sanofi Pasteur Description and Major Businesses
 Table 52. Sanofi Pasteur Product Models, Descriptions and Specifications
 Table 53. Sanofi Pasteur Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. Sanofi Pasteur Sales Value Proportion by Product in 2024
 Table 55. Sanofi Pasteur Sales Value Proportion by Application in 2024
 Table 56. Sanofi Pasteur Sales Value Proportion by Geographic Area in 2024
 Table 57. Sanofi Pasteur Pertussis Booster Vaccine SWOT Analysis
 Table 58. Sanofi Pasteur Recent Developments
 Table 59. GSK Corporation Information
 Table 60. GSK Description and Major Businesses
 Table 61. GSK Product Models, Descriptions and Specifications
 Table 62. GSK Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. GSK Sales Value Proportion by Product in 2024
 Table 64. GSK Sales Value Proportion by Application in 2024
 Table 65. GSK Sales Value Proportion by Geographic Area in 2024
 Table 66. GSK Pertussis Booster Vaccine SWOT Analysis
 Table 67. GSK Recent Developments
 Table 68. Mitsubishi Tanabe Pharma Corporation Information
 Table 69. Mitsubishi Tanabe Pharma Description and Major Businesses
 Table 70. Mitsubishi Tanabe Pharma Product Models, Descriptions and Specifications
 Table 71. Mitsubishi Tanabe Pharma Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Mitsubishi Tanabe Pharma Sales Value Proportion by Product in 2024
 Table 73. Mitsubishi Tanabe Pharma Sales Value Proportion by Application in 2024
 Table 74. Mitsubishi Tanabe Pharma Sales Value Proportion by Geographic Area in 2024
 Table 75. Mitsubishi Tanabe Pharma Pertussis Booster Vaccine SWOT Analysis
 Table 76. Mitsubishi Tanabe Pharma Recent Developments
 Table 77. KM Biologics Corporation Information
 Table 78. KM Biologics Description and Major Businesses
 Table 79. KM Biologics Product Models, Descriptions and Specifications
 Table 80. KM Biologics Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. KM Biologics Sales Value Proportion by Product in 2024
 Table 82. KM Biologics Sales Value Proportion by Application in 2024
 Table 83. KM Biologics Sales Value Proportion by Geographic Area in 2024
 Table 84. KM Biologics Pertussis Booster Vaccine SWOT Analysis
 Table 85. KM Biologics Recent Developments
 Table 86. Wuhan Institute of Biological Products Corporation Information
 Table 87. Wuhan Institute of Biological Products Description and Major Businesses
 Table 88. Wuhan Institute of Biological Products Product Models, Descriptions and Specifications
 Table 89. Wuhan Institute of Biological Products Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Wuhan Institute of Biological Products Sales Value Proportion by Product in 2024
 Table 91. Wuhan Institute of Biological Products Sales Value Proportion by Application in 2024
 Table 92. Wuhan Institute of Biological Products Sales Value Proportion by Geographic Area in 2024
 Table 93. Wuhan Institute of Biological Products Pertussis Booster Vaccine SWOT Analysis
 Table 94. Wuhan Institute of Biological Products Recent Developments
 Table 95. Walvax Biotechnology Corporation Information
 Table 96. Walvax Biotechnology Description and Major Businesses
 Table 97. Walvax Biotechnology Product Models, Descriptions and Specifications
 Table 98. Walvax Biotechnology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. Walvax Biotechnology Recent Developments
 Table 100. Chengdu Institute of Biological Products Corporation Information
 Table 101. Chengdu Institute of Biological Products Description and Major Businesses
 Table 102. Chengdu Institute of Biological Products Product Models, Descriptions and Specifications
 Table 103. Chengdu Institute of Biological Products Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Chengdu Institute of Biological Products Recent Developments
 Table 105. Minhai Biotechnology Corporation Information
 Table 106. Minhai Biotechnology Description and Major Businesses
 Table 107. Minhai Biotechnology Product Models, Descriptions and Specifications
 Table 108. Minhai Biotechnology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. Minhai Biotechnology Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pertussis Booster Vaccine Product Picture
 Figure 2. Global Pertussis Booster Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Acellular Vaccines Product Picture
 Figure 4. Whole-Cell Vaccines Product Picture
 Figure 5. Global Pertussis Booster Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. 12 Months Below
 Figure 7. 12 Months Above
 Figure 8. Pertussis Booster Vaccine Report Years Considered
 Figure 9. Global Pertussis Booster Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Pertussis Booster Vaccine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Pertussis Booster Vaccine Revenue Market Share by Region (2020-2031)
 Figure 13. Global Pertussis Booster Vaccine Sales (2020-2031) & (K Dose)
 Figure 14. Global Pertussis Booster Vaccine Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 15. Global Pertussis Booster Vaccine Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Pertussis Booster Vaccine Sales Volume Market Share in 2024
 Figure 17. Global Pertussis Booster Vaccine Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Acellular Vaccines Revenue Market Share by Manufacturer in 2024
 Figure 20. Whole-Cell Vaccines Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Pertussis Booster Vaccine Sales Market Share by Type (2020-2031)
 Figure 22. Global Pertussis Booster Vaccine Revenue Market Share by Type (2020-2031)
 Figure 23. Global Pertussis Booster Vaccine Sales Market Share by Application (2020-2031)
 Figure 24. Global Pertussis Booster Vaccine Revenue Market Share by Application (2020-2031)
 Figure 25. North America Pertussis Booster Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 26. North America Pertussis Booster Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Pertussis Booster Vaccine Sales Revenue (US$ Million) in 2024
 Figure 28. North America Pertussis Booster Vaccine Sales Volume (K Dose) by Type (2020- 2031)
 Figure 29. North America Pertussis Booster Vaccine Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Pertussis Booster Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 31. North America Pertussis Booster Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Pertussis Booster Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 36. Europe Pertussis Booster Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Pertussis Booster Vaccine Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Pertussis Booster Vaccine Sales Volume (K Dose) by Type (2020-2031)
 Figure 39. Europe Pertussis Booster Vaccine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Pertussis Booster Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 41. Europe Pertussis Booster Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 43. France Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Pertussis Booster Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 48. Asia-Pacific Pertussis Booster Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Pertussis Booster Vaccine Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Pertussis Booster Vaccine Sales Volume (K Dose) by Type (2020- 2031)
 Figure 51. Asia-Pacific Pertussis Booster Vaccine Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Pertussis Booster Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 53. Asia-Pacific Pertussis Booster Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 58. India Pertussis Booster Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Pertussis Booster Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 60. Central and South America Pertussis Booster Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Pertussis Booster Vaccine Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Pertussis Booster Vaccine Sales Volume (K Dose) by Type (2021-2031)
 Figure 63. Central and South America Pertussis Booster Vaccine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Pertussis Booster Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 65. Central and South America Pertussis Booster Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Pertussis Booster Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Pertussis Booster Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Pertussis Booster Vaccine Sales YoY (2020-2031) & (K Dose)
 Figure 69. Middle East and Africa Pertussis Booster Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Pertussis Booster Vaccine Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Pertussis Booster Vaccine Sales Volume (K Dose) by Type (2021-2031)
 Figure 72. South America Pertussis Booster Vaccine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Pertussis Booster Vaccine Sales Volume (K Dose) by Application (2020-2031)
 Figure 74. Middle East and Africa Pertussis Booster Vaccine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Pertussis Booster Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Pertussis Booster Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Pertussis Booster Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Pertussis Booster Vaccine Revenue (2020-2025) & (US$ Million)
 Figure 79. Pertussis Booster Vaccine Industry Chain Mapping
 Figure 80. Regional Pertussis Booster Vaccine Manufacturing Base Distribution (%)
 Figure 81. Global Pertussis Booster Vaccine Production Market Share by Region (2020-2031)
 Figure 82. Pertussis Booster Vaccine Production Process
 Figure 83. Regional Pertussis Booster Vaccine Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Pertussis Vaccination Market Research Report 2025
Global Pertussis Vaccine Market Insights Forecast to 2030
Global Whooping Cough Preventable Vaccine Market Research Report 2024
Global Diphtheria Tetanus and Pertussis DTaP Vaccine Market Research Report 2024
Global Pertussis Treatment Market Research Report 2024
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2024
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025
Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2024
Global Bordetella Pertussis ELISA Kits Market Research Report 2024
Global Combined Polio Vaccine Market Research Report 2024
Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bordetella Pertussis Test Kit Market Research Report 2024
Global Pediatric Preventable Vaccine Market Research Report 2024
Global Rotavirus Vaccine Market Research Report 2024
Global Poliomyelitis Vaccine Market Research Report 2025
Global Polio Vaccination Market Research Report 2025
Global Immune System Booster Market Research Report 2024
Global Bordetella Pertussis Nucleic Acid Detection Kit Market Research Report 2024
Global Pentavalent Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions